Bavarsadkarimi Minoodokht, Omidi Sirous, Shahmoradi Farinaz, Heidar Zahra, Mirzaei Sahar
Clinical Research Development Center, Mahdiyeh Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran.
Abadan University of Medical Sciences and Health Services, Abadan.
Eur J Transl Myol. 2022 Jul 6;32(3):10634. doi: 10.4081/ejtm.2022.10634.
This is a randomized controlled trial conducted in a tertiary referral fertility department. Participants were women with previous poor ovarian response undergoing in vitro fertilization. (IVF). One hundred and ninety-two women were randomized to the short GnRH agonist and antagonist regimens. The primary outcome was the number of oocytes retrieved. Secondary outcome measures were the number of embryos transferred, chemical and clinical pregnancy rate and live birth. The number of oocytes retrieved was higher with the gonadotrophin-releasing hormone (GnRH) antagonist regimen compared to the short agonist regimen (3.10 2.70 vs. 2.992.60), but there was no significant difference. The duration of stimulation and total gonadotropin dose were higher with short agonist regimens compared to antagonist regimens, with the latter being statistically significant (p < 0.001). The chemical pregnancy rate was 8.33 percent with the short agonist regimen and 7.29 percent with the antagonist regimen, with no statistically significant difference (p = 0.79). In terms of lower cycles cancelation and higher chemical pregnancy, short GnRH agonist regim is appropriate choice for poor responders.
这是一项在三级转诊生殖科进行的随机对照试验。参与者为既往卵巢反应不良且正在接受体外受精(IVF)的女性。192名女性被随机分为短效促性腺激素释放激素(GnRH)激动剂方案组和拮抗剂方案组。主要结局是获卵数。次要结局指标包括移植胚胎数、生化妊娠率、临床妊娠率和活产率。与短效激动剂方案相比,GnRH拮抗剂方案的获卵数更高(3.10±2.70 vs. 2.99±2.60),但无显著差异。与拮抗剂方案相比,短效激动剂方案的刺激时间和促性腺激素总剂量更高,后者具有统计学意义(p<0.001)。短效激动剂方案的生化妊娠率为8.33%,拮抗剂方案为7.29%,无统计学显著差异(p = 0.79)。就较低的周期取消率和较高的生化妊娠而言,短效GnRH激动剂方案是反应不良者的合适选择。